Cargando…

SARS-CoV-2 vaccine strategies in kidney transplant recipients

Detalles Bibliográficos
Autores principales:	Prendecki, Maria, Willicombe, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612841/ https://www.ncbi.nlm.nih.gov/pubmed/36354033 http://dx.doi.org/10.1016/S1473-3099(22)00666-1

Ejemplares similares

Single-dose SARS-CoV-2 vaccination efficacy in the elderly
por: Prendecki, Maria, et al.
Publicado: (2021)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2021)

SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19
por: Heimbach, Julie K, et al.
Publicado: (2020)

SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19
por: Prendecki, Maria, et al.
Publicado: (2020)

COVID-19 vaccination in kidney transplant recipients
por: Caillard, Sophie, et al.
Publicado: (2021)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT
por: Leclerc, Mathieu, et al.
Publicado: (2022)

Risks of lung transplantation in the SARS-CoV-2 era
por: Meyer, Keith C
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation
por: Gleeson, Sarah, et al.
Publicado: (2023)

Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection
por: Weber, Sven C., et al.
Publicado: (2022)

Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients
por: Frölke, Sophie C., et al.
Publicado: (2022)

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

SARS-CoV-2 evolution and vaccines: cause for concern?
por: Williams, Thomas C, et al.
Publicado: (2021)

Stroke after SARS-CoV-2 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023)

The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
por: Shang, Weilong, et al.
Publicado: (2020)

SARS-CoV-2 vaccines: fast track versus efficacy
por: Alkandari, Dana, et al.
Publicado: (2021)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

Balancing risk and benefit of SARS-CoV-2 vaccines in children
por: Levin, Michael, et al.
Publicado: (2022)

Affordable SARS-CoV-2 protein vaccines for the pandemic endgame
por: Triccas, James A., et al.
Publicado: (2022)

Guillain-Barre syndrome related to SARS-CoV-2 vaccinations
por: Finsterer, Josef, et al.
Publicado: (2022)

Stroke seven hours after SARS-CoV-2 vaccination
por: Fiorini, Ana Claudia, et al.
Publicado: (2023)

SARS-CoV-2 transmission: time to rethink public health strategy
por: Parker, Arifa, et al.
Publicado: (2022)

Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine
por: Ou, Michael T., et al.
Publicado: (2021)

Declined Humoral Immunity of Kidney Transplant Recipients to SARS-CoV-2 Vaccines
por: Mahallawi, Waleed H, et al.
Publicado: (2023)

A promising inactivated whole-virion SARS-CoV-2 vaccine
por: Isakova-Sivak, Irina, et al.
Publicado: (2021)

SARS-CoV-2 vaccination and phase 1 cancer clinical trials
por: Yap, Timothy A, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in IBD: more pros than cons
por: D’Amico, Ferdinando, et al.
Publicado: (2021)

Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine
por: Kennedy, Richard B
Publicado: (2022)

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
por: Lim, Sean H, et al.
Publicado: (2021)

SARS-CoV-2 and HIV-1 — a tale of two vaccines
por: Haynes, Barton F.
Publicado: (2021)

Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022)

Effectiveness of SARS-CoV-2 vaccines in the post-natural infection world
por: Garg, Pramod Kumar, et al.
Publicado: (2022)

Neonatal SARS-CoV-2 infection
por: de Carvalho, Werther Brunow, et al.
Publicado: (2020)

Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2
por: Zhang, Yi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4v10rg9937e5uqgj596vu1cqll